ABSTRACT
BACKGROUND: This study aimed to profile the clinical characteristics of patients presenting to Middlemore Hospital with cellulitis in order to identify factors that are associated with an increased length of stay (LOS). METHODS: Retrospective clinical data were collected for all patients aged 18 and above who were admitted with cellulitis to Middlemore Hospital General Surgical Department between 1 January and 31 March 2014. Comorbidities, laboratory results and medical conditions were included in the investigation. RESULTS: The study included 201 patients. Significant factors associated with increased LOS include type 2 diabetes mellitus (P < 0.012), obesity (P < 0.001), raised C-reactive protein (P < 0.0001), raised white cell count (P < 0.0001), raised temperature (P < 0.0001), septic shock (P < 0.003), multiorgan failure (P < 0.01), extended-spectrum beta-lactamases or methicillin-resistant Staphylococcus aureus colonization (P < 0.04) and intensive care unit admission (P < 0.0004). CONCLUSION: This single-centre, retrospective clinical study has identified several factors that are significantly associated with an increased LOS. These factors provide a basis for future studies that may facilitate identification and timely medical optimization of high-risk patients.
Subject(s)
Cellulitis/epidemiology , Hospitalization/statistics & numerical data , Intensive Care Units/statistics & numerical data , Length of Stay/statistics & numerical data , C-Reactive Protein/metabolism , Colony Count, Microbial/trends , Comorbidity , Diabetes Mellitus, Type 2/epidemiology , Female , Fever/epidemiology , Hospitalization/trends , Humans , Length of Stay/trends , Leukocytosis/epidemiology , Male , Methicillin-Resistant Staphylococcus aureus/growth & development , Multiple Organ Failure/epidemiology , New Zealand/epidemiology , Obesity/epidemiology , Retrospective Studies , Risk Factors , Shock, Septic/epidemiologyABSTRACT
OBJECTIVE: To develop a national scorecard for assessing health system performance derived from routine data. METHODS: We drew upon national and international data to develop benchmarks for health system performance, then applied basic ratio scores to compare New Zealand performances to the benchmark. 64 indicators were included in four assessment categories: healthy lives, quality, access, and efficiency. In a fifth category, 27 of these indicators were used to score health system equity. Indicator scores in each category were then averaged to give a health system score out of 100. RESULTS: New Zealand's health system achieved an overall score of 71 out of 100. The system scored relatively well on quality and efficiency, but poorly on equity despite considerable government investment in reducing inequalities. CONCLUSIONS: The scorecard offers a useful method for combining a range of data to give an overall picture of health system performance, highlighting strengths, weaknesses and areas for improvement. This initial study provides a baseline for assessing New Zealand's performance over time and, where data permit, a template for other countries to follow.
Subject(s)
Delivery of Health Care/standards , Quality Assurance, Health Care/methods , Benchmarking/methods , Benchmarking/standards , Efficiency, Organizational/standards , Health Services Accessibility/standards , Health Status Indicators , Healthcare Disparities/standards , Humans , New Zealand , Quality Assurance, Health Care/standards , Quality Indicators, Health Care/standardsABSTRACT
Potent, small molecule A beta inhibitors have been prepared that incorporate an alanine core bracketed by an N-terminal arylacetyl group and various C-terminal amino alcohols. The compounds exhibit stereospecific inhibition as demonstrated in an in vitro assay.
